Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models.
Saved in:
| Title: | Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models. |
|---|---|
| Authors: | Johnson, Michael P1 johnson_michael_p@lilly.com, Muhlhauser, Mark A1, Nisenbaum, Eric S1, Simmons, Rosa M A1, Forster, Beth M1, Knopp, Kelly L1, Yang, Lijuan1, Morrow, Denise1, Li, Dominic L1, Kennedy, Jeffrey D1, Swanson, Steven1, Monn, James A1 |
| Source: | British Journal of Pharmacology. May2017, Vol. 174 Issue 9, p822-835. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
